These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Gd-DTPA adrenal gland enhancement at 1.5 T. Small WC; Bernardino ME Magn Reson Imaging; 1991; 9(3):309-12. PubMed ID: 1881248 [TBL] [Abstract][Full Text] [Related]
47. Use of acute phase proteins in pleural effusion discrimination. Calikoğlu M; Sezer C; Unlü A; Kanik A; Tamer L; Calikoğlu I Tuberk Toraks; 2004; 52(2):122-9. PubMed ID: 15241695 [TBL] [Abstract][Full Text] [Related]
48. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944 [TBL] [Abstract][Full Text] [Related]
49. [Transudative pleural effusions and the ovarian hyperstimulation syndrome]. Boutemy M; Buklow K; Glérant JCh; Martin F; Jounieaux V Rev Mal Respir; 2003 Feb; 20(1 Pt 1):134-9. PubMed ID: 12709642 [TBL] [Abstract][Full Text] [Related]
50. Evaluating diagnostic tests in the pleural space. Differentiating transudates from exudates as a model. Heffner JE Clin Chest Med; 1998 Jun; 19(2):277-93. PubMed ID: 9646981 [TBL] [Abstract][Full Text] [Related]
51. The dynamics of extracellular gadolinium-based contrast agent excretion into pleural and pericardial effusions quantified by T1 mapping cardiovascular magnetic resonance. Thalén S; Maanja M; Sigfridsson A; Maret E; Sörensson P; Ugander M J Cardiovasc Magn Reson; 2019 Nov; 21(1):71. PubMed ID: 31730498 [TBL] [Abstract][Full Text] [Related]
53. Increased oxidative stress in exudative pleural effusions: a new marker for the differentiation between exudates and transudates? Papageorgiou E; Kostikas K; Kiropoulos T; Karetsi E; Mpatavanis G; Gourgoulianis KI Chest; 2005 Nov; 128(5):3291-7. PubMed ID: 16304274 [TBL] [Abstract][Full Text] [Related]
54. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions. Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224 [TBL] [Abstract][Full Text] [Related]
55. A study of Light's criteria and possible modifications for distinguishing exudative from transudative pleural effusions. Vives M; Porcel JM; Vicente de Vera M; Ribelles E; Rubio M Chest; 1996 Jun; 109(6):1503-7. PubMed ID: 8769501 [TBL] [Abstract][Full Text] [Related]
56. Decision making and algorithm for the management of pleural effusions. Quinn T; Alam N; Aminazad A; Marshall MB; Choong CK Thorac Surg Clin; 2013 Feb; 23(1):11-6, v. PubMed ID: 23206713 [TBL] [Abstract][Full Text] [Related]
57. [Biological criteria for distinguishing exudative and transudative pleural effusions. Usefulness in a general hospital]. Gouteux-Frezzotti D; Bolard F; Ramon PM; Steenhouwer F Rev Pneumol Clin; 2002 Feb; 58(1):11-6. PubMed ID: 11981499 [TBL] [Abstract][Full Text] [Related]
58. Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions. Tomimoto H; Yano S; Muguruma H; Kakiuchi S; Sone S J Med Invest; 2007 Feb; 54(1-2):146-53. PubMed ID: 17380026 [TBL] [Abstract][Full Text] [Related]